Comparative evaluation of lethal outcome prediction methods in severely burned patients von Zavorotniy, O. O., Zinoviev, E. V., Volkov, V. G., Kostyakov, D. V., Halipaeva, D. H., Semiglazov, A. V., Gogohiya, T. Z.

Volltext

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 von Curigliano, G, Burstein, H J, P. Winer, E, Gnant, M, Dubsky, P, Loibl, S, Colleoni, M, Regan, M M, Piccart-Gebhart, M, Senn, H -J, Thürlimann, B

Volltext

Corrections to “De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Brea... von Curigliano, G., Burstein, H.J., P. Winer, E., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M.M., Piccart-Gebhart, M., Senn, H.-J., Thürlimann, B., André, F., Baselga, J., Bergh, J., Bonnefoi, H., Y. Brucker, S., Cardoso, F., Carey, L., Ciruelos, E., Cuzick, J., Denkert, C., Di Leo, A., Ejlertsen, B., Francis, P., Galimberti, V., Garber, J., Gulluoglu, B., Goodwin, P., Harbeck, N., Hayes, D.F., Huang, C.-S., Huober, J., Khaled, H., Jassem, J., Jiang, Z., Karlsson, P., Morrow, M., Orecchia, R., Osborne, K.C., Pagani, O., Partridge, A.H., Pritchard, K., Ro, J., Rutgers, E.J.T., Sedlmayer, F., Semiglazov, V., Shao, Z., Smith, I., Toi, M., Tutt, A., Viale, G., Watanabe, T., Whelan, T.J., Xu, B.

Volltext

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospect... von Mieog, J Sven D, MD, Morden, James P, MSc, Bliss, Judith M, Prof, Coombes, R Charles, Prof, van de Velde, Cornelis JH, Prof

Volltext

Heat exchange in film boiling of cryogenic liquids under natural convection conditions von Kurilenko, A. A., Semiglazov, V. A., Panevin, V. I., Dymenko, S. K., Firsov, V. P.

Volltext

Heterogeneous nucleation mechanism in the flow of a superheated cryogenic liquid von Blinkov, V. N., Dymenko, S. K., Kurilenko, A. A., Semiglazov, V. A., Soplenkov, K. I., Frolov, S. D.

Volltext

Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangel... von Gianni, L., Huang, C.S., Egle, D., Bermejo, B., Zamagni, C., Thill, M., Anton, A., Zambelli, S., Bianchini, G., Russo, S., Ciruelos, E.M., Greil, R., Semiglazov, V., Colleoni, M., Kelly, C., Mariani, G., Del Mastro, L., Maffeis, I., Valagussa, P., Viale, G.

Volltext

RECIST for Response (Clinical and Imaging) in Neoadjuvant Clinical Trials in Operable Breast Cancer von Semiglazov, Vladimir

Volltext

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer von Swain, Sandra M, Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C, Cortés, Javier

Volltext

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer von Semiglazov, Vladimir F., Semiglazov, Vladislav V., Dashyan, Garik A., Ziltsova, Elena K., Ivanov, Vadim G., Bozhok, Alla A., Melnikova, Olga A., Paltuev, Ruslan M., Kletzel, Alexander, Berstein, Lev M.

Volltext

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally adv... von Miles, D., Gligorov, J., Cameron, D., Xu, B., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Patel, S.L., Barata, T., Xu, B., Shao, Z., Wang, X., Geng, C., Yan, X., Tong, Z., Sun, T., Yang, J., Liu, Q., Zhang, S., De Laurentiis, M., Santoro, A., Colleoni, M., Cortesi, L., Placido, S., Ferrau, F., Del Mastro, L., Tonini, G., Montemurro, F., Bianchi, G., Prete, S., Allegrini, G., Naso, G., Vici, P., Loirat, D., Tredan, O., Gligorov, J., Timar David, M., Dohollou, N., Spano, J.-P., Mansi, L., Andrade, L., Damian, F., Aleixo, S., Junior, R., Reinisch, M., Grischke, E.-M., Harbeck, N., Peters, U., Fischer, D., Forstbauer, H., Warner, E., Bouganim, N., Vandenberg, T., Pavic, M., Robinson, A., Califaretti, N., Alacacioglu, A., Gumus, M., Yalcin, B., Cicin, I., Kose, F., Cubukcu, E., Wardley, A., Miles, D., Gupta, S., Mohapatra, P., Ghadyalpatil, N., Singhal, M., Agarwal, A., Wolf, I., Gal Yam, E., Yerushalmi, R., Peretz, T., Ben Baruch, N., Hamilton, E., Brufsky, A., Wright, G., Graff, S., Semiglazov, V., Ruiz Borrego, M., Merino, L., Guerra Martinez, J., Ohtani, S., Inoue, K., Ito, Y., Niikura, N., Sagara, Y., Yanagita, Y., Kaen, D., Nervo, A., Melichar, B., Sormova, P., Sufliarsky, J., Kakalejcik, M., Belbaraka, R., Errihani, H., Le Than, D., Pham, D., Papandreou, C.

Volltext

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer von Baselga, J., Manikhas, A., Cortés, J., Llombart, A., Roman, L., Semiglazov, V.F., Byakhov, M., Lokanatha, D., Forenza, S., Goldfarb, R.H., Matera, J., Azarnia, N., Hudis, C.A., Rozencweig, M.

Volltext

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006 von Kaufmann, M., von Minckwitz, G., Bear, H.D., Buzdar, A., McGale, P., Bonnefoi, H., Colleoni, M., Denkert, C., Eiermann, W., Jackesz, R., Makris, A., Miller, W., Pierga, J.-Y., Semiglazov, V., Schneeweiss, A., Souchon, R., Stearns, V., Untch, M., Loibl, S.

Volltext

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breas... von GIANNI, Luca, ROMIEU, Gilles H, CHAN, Stephen, WARDLEY, Andrew, GREIL, Richard, MOORE, Nicola, PROT, Sylvie, PALLAUD, Celine, SEMIGLAZOV, Vladimir, LICHINITSER, Michail, SERRANO, Sergio V, MANSUTTI, Mauro, PIVOT, Xavier, MARIANI, Paola, ANDRE, Fabrice, CHAN, Arlene, LIPATOV, Oleg

Volltext

CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Re... von Pivot, Xavier, Manikhas, Alexey, Żurawski, Bogdan, Chmielowska, Ewa, Karaszewska, Boguslawa, Allerton, Rozenn, Chan, Stephen, Fabi, Alessandra, Bidoli, Paolo, Gori, Stefania, Ciruelos, Eva, Dank, Magdolna, Hornyak, Lajos, Margolin, Sara, Nusch, Arnd, Parikh, Roma, Nagi, Fareha, DeSilvio, Michelle, Santillana, Sergio, Swaby, Ramona F, Semiglazov, Vladimir

Volltext

General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16th th International Breast Cancer Conference) von Semiglazov, V. F., Paltuev, R. M., Semiglazov, V. V.

Volltext

Intraoperative evaluation of the resection margin with the usage of digital two-point sectorography (Faxitron PathVision) von Bondarchuk, Ya. I., Zhiltsova, E. K., Krivorotko, P. V., Pesotskiy, R. S., Emelyanov, A. S., Tabagua, T. T., Gigolaeva, L. P., Yereshchenko, S. S., Komyakhov, A. V., Nikolaev, K. S., Zernov, K. Yu, Semiglazov, V. V., Paltuev, R. M., Mortada, V. V., Shaykhelislamova, L. F., Enaldieva, D. A., Amirov, N. S., Channov, V. S., Artemyeva, A. S., Chernaya, A. V., Ulyanova, R. Kh, Semiglazov, V. F.

Volltext

The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer afte... von Enaldieva, D. A., Krivorotko, P. V., Imyanitov, E. N., Zhiltsova, E. K., Donskikh, R. V., Sokolenko, A. P., Shaykhelislamova, L. F., Tabagua, T. T., Gigolaeva, L. P., Komyakhov, A. V., Nikolaev, K. S., Zernov, K. Yu, Ereshchenko, S. S., Paltuev, R. M., Bessonov, A. A., Artemyeva, A. S., Pesotskiy, R. S., Amirov, N. S., Emelyanov, A. S., Mortada, V. V., Bondarchuk, Ya. I., Semiglazov, V. V., Semiglazova, T. Yu, Semiglazov, V. F., Belyaev, A. M.

Volltext

Quality of Life is Improved in Breast Cancer Patients by Standardised Mistletoe Extract PS76A2 during Chemotherapy and Follow-up: A Randomised, Placebo-controlled, Double-blind, Mu... von SEMIGLAZOV, V. F, STEPULA, V. V, DUDOV, A, SCHNITKER, J, MENGS, U

Volltext

Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial von Bianchini, G., Pusztai, L., Pienkowski, T., Im, Y.-H., Bianchi, G.V., Tseng, L.-M., Liu, M.-C., Lluch, A., Galeota, E., Magazzù, D., de la Haba-Rodríguez, J., Oh, D.-Y., Poirier, B., Pedrini, J.L., Semiglazov, V., Valagussa, P., Gianni, L.

Volltext